|
|
|
|
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
|
||
(Address of Principal Executive Offices)
|
(Zip Code) |
|
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425).
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
|
Title of each class
|
Trading
Symbols
|
Name of each exchange
on which registered
|
||
|
||||
N.A
|
(1)
|
Exhibit No.
|
Description
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
KALTURA, INC.
|
|||
Date: January 16, 2024
|
By:
|
/s/ Zvi Maayan
|
|
Name: Zvi Maayan
|
|||
Title: General Counsel and Corporate Secretary
|
1. |
Base Salary – Subject to your continued
employment by Kaltura, your annual base salary will be at a gross amount of at least $470,000 (four hundred and seventy thousand US Dollars). Your base salary may be increased but shall not be decreased (your base salary as adjusted, the “Base Salary”) payable in twenty-four semi-monthly pay period installments (i.e., a 2-weeks payment twice a month). All payments by the
Company to you hereunder of any kind will be subject to the withholding of federal and state taxes and other authorized deductions and governmental assessments required pursuant to any applicable law. This is a Full-Time position.
|
2. |
Benefits – Subject to your continued
employment by Kaltura as a full-time employee, you will be eligible to participate in and to receive benefits under such plans and benefits as may be offered to other employees of the Company who hold positions of similar responsibility as
yours, if and to the extent adopted, implemented and approved by the Company. The eligibility criteria and amount and extent of benefits to which you may be entitled will be governed by the specific benefit plan and will be subject to any
applicable policy of the Company, as may be updated from time to time in the Company’s sole discretion. For additional details on available benefits, please refer to the specific benefit plan document.
|
3. |
Additional Compensation – Subject to your
continued employment by Kaltura, you will be eligible to receive additional performance-based compensation (the “Performance Based Compensation”)
as follows:
|
3.1. |
For your employment term during 2024 from the Effective Date until December 31st, 2024, (i) the Pro-Rata portion of the 2024 MBO performance based
compensation, and (ii) the Initial LTI, each as set forth in Exhibit A.1. and Exhibit A.1.(a) hereof; and
|
3.2. |
For your employment term from January 1st, 2025 until the effective date of termination of your employment, MBO performance based compensation in
accordance with the plan attached hereto as Exhibit A.2., as may be updated by the Company from time-to-time and additional LTI performance based
compensation as shall be determined by the Company from time to time.
|
Kaltura, Inc. • 860 Broadway, 3rd Floor New York, NY 10003 • Tel: 646-290-5445
Kaltura (Europe) Ltd. • 4th Floor, LABs House, 16-19 Bloomsbury, London, WC1A 2BA, UK
Kaltura Ltd. • Allied Tower, 9 Ben-Gurion Road, Bnei-Brak, Israel 5126014
|
www.kaltura.com
|
4. |
Reimbursement of Expenses – You will be
eligible for reimbursement of pre-approved reasonable and necessary expenses incurred by you in furtherance of the Company’s business, in accordance with the Company’s travel and expense policies, as may be updated from time to time in the
Company’s sole discretion. Without limiting the generality of the foregoing, the Company will reimburse you for monthly cell phone and internet costs, up to $200 per month, against receipts. Within fifteen (15) days of your execution of
this Agreement, the Company shall directly pay by wire to Outten & Golden LLP the reasonable legal fees actually incurred by you in connection with the review and negotiation of this Agreement. Outten & Golden LLP shall provide the
Company with a Form W-9 for this payment, and the Company shall provide both Outten & Golden LLP and you with a Form 1099.
|
5. |
Paid Time Off – You will be eligible to
accrue up to seventeen (17) days of paid time off (“PTO”) and three (3) floating holidays (“FLH”) per year, subject to the terms and conditions of the Company’s policies on leave and paid time off, as may be updated from time to time in the Company’s sole discretion.
|
6. |
Reporting – You will report directly to
the Company’s Chief Executive Officer.
|
7. |
Work Location – You will be working on a hybrid model -
according to the Company policy, your employment with the Company will be based on a hybrid work model. Accordingly, you shall be requested to attend the NY office of the Company at least 5 working days per month, in addition to
periodic visits to the Tel-Aviv office of the Company and otherwise will be permitted to work from your home or another location of your choosing.
|
8. |
Company Rules; Representations – As an
employee of the Company, you will be expected to abide by the Company’s policies, rules, and regulations, including the Company’s Code of Business Conduct and Ethics, which is available on the Company’s website at: https://investors.kaltura.com/corporate-governance/governance-overview. As a condition to your employment with the Company, you will be required to sign (i) an
acknowledgment that you have read and understood the Company rules of conduct as provided in the Company’s Employee Handbook (the “Employee
Handbook Acknowledgment”); and (ii) the employment representation statement attached hereto as Exhibit B (the “Employment Representation Statement”).
|
9. |
Section 16 Officer – as a CFO, you will be
a Section 16 Officer. Accordingly, among other things, you shall be subject to enhanced responsibility and liability, and certain reporting obligations and trade restrictions. You shall be requested to provide your EDGAR Code should you
want the Company to make such SEC filings for you. You shall be requested to execute an acknowledgement and consent to the Company’s Clawback Policy, and it is advisable that you establish a Rule 10b5-1 plan.
|
10. |
Background Check – The offer of employment
set forth in this Letter is contingent upon successful completion of a background investigation in accordance with Kaltura’s standard background check policies.
|
11. |
Additional Terms – Normal business hours
are from 9:00 a.m. to 5:00 p.m., Monday through Friday. As an exempt salaried employee, you will be expected to work additional hours as required by the nature of your work assignments, however, you will not be eligible for overtime pay.
You must establish your identity and authorization to work as required by the Immigration Reform and Control Act of 1986 (“IRCA”) and
other applicable laws. Enclosed is a copy of the Employment Verification Form and W-4, with instructions required by IRCA. Please review this document and bring the appropriate original documentation on your first day of work. Additionally,
you may be required to verify your former employment and supply official documents related to any educational diploma you claim to have.
|
12. |
Term & Termination – Your employment
with the Company will commence on the Effective Date, for an indefinite period until the termination thereof by either party in accordance with the terms hereof or as shall further be set forth in the definitive employment agreement (the “Term” or “Term of Employment”). You
may terminate your employment with the Company at any time and for any reason whatsoever, by providing the Company a 60-day advanced written notice of termination (“Advanced Termination Notice”) and likewise, in the event of termination of the Term by the Company without Cause (as such term shall be defined in the definitive employment agreement), you shall also be entitled
to receive from the Company an Advanced Termination Notice or payment of the monthly Base Salary in lieu thereof (without perquisites), as the Company may elect at its sole and absolute discretion. If your employment ends for any reason,
you shall be entitled to payment of (i) your unpaid Base Salary through the date of termination; (ii) all of your accrued, but unused paid time off; (iii) any unpaid expense reimbursements incurred by you as of the date of termination; and
(iv) any earned but unpaid Performance Based Compensation from a prior fiscal year ((i) through (iv), the “Accrued Obligations”).
|
13. |
Severance Pay – if and in the event that the Company shall terminate the Term of Employment without Cause (as such term is defined below) or for Good Reason (as such term is
defined below), then, in addition to the Accrued Obligations, you shall be entitled to a Severance Pay that shall include the following: (i) a cash payment equal to 6-months Base Salary in three subsequent bi-monthly installments of
2-months Base Salary each; (ii) a cash payment equal to a pro-rata portion of your annual Performance Based Compensation entitlement on the basis of your and the Company’s attainment of certain goals and objectives as shall be defined by
the Company and set forth in your annual bonus plan according to the then current Company’s Executive Compensation Plan, with respect to your actual employment Term throughout such year; and (iii) Kaltura will subsidize Cobra coverage for a
6-month period commencing upon the expiry of the Employment Term.
|
14. |
Definitions – As used herein:
|
14.1. |
“Cause” shall mean, unless such term or an equivalent term is
otherwise defined by any employment agreement or offer letter between the Employee and the Company, any of the following: (i) the Employee’s theft, dishonesty, willful misconduct, breach of fiduciary duty for personal profit, or
falsification of the Company’s documents or records; (ii) the Employee’s material failure to abide by the Company’s code of conduct or other policies (including, without limitation, policies relating to confidentiality and reasonable
workplace conduct); (iii) the Employee’s unauthorized use, misappropriation, destruction or diversion of any tangible or intangible asset or corporate opportunity of the Company (including, without limitation, the Employee’s improper use or
disclosure of the Company’s confidential or proprietary information); (iv) any intentional act by the Employee which has a material detrimental effect on the Company’s reputation or business or which brings the Employee into widespread
public disrepute; (v) the Employee’s repeated failure or inability to perform any reasonable assigned duties after written notice from the Company of, and a reasonable opportunity to cure, such failure or inability; (vi) any material breach
by the Employee of any employment or service agreement between the Employee and the Company, which breach is not cured pursuant to the terms of such agreement; or (vii) the Employee’s commission or conviction (including any plea of guilty
or nolo contendere) of any criminal act involving fraud, dishonesty, misappropriation or moral turpitude, or which impairs the Employee’s ability to perform his or her duties with the Company. For purposes of this Agreement, whether or not
an event giving rise to “Cause” occurs will be determined by the Board in its sole discretion.
|
14.2. |
“Good Reason” shall mean, unless such term or an equivalent
term is otherwise defined by any employment agreement or offer letter between the Employee and the Company, the occurrence of any of the following without the Employee’s voluntary written consent: (i) a material breach by the Company of any
material provision of this Agreement of any employment or service agreement between the Employee and the Company; (ii) a reduction resulting in the value of the Employee’s salary and/or the monetary value of Employee’s benefits, of more
than 12.5%, unless such reductions are made in the same proportion as part of across-the-board salary reductions for substantially all other employees with a similar level; (iii) the Company’s relocation of the Company office to which the
Employee primarily reports (the “Office”) to a location that increases the distance from the Employee’s principal residence to the Office by more than fifty (50) miles; or (iv) a substantial diminution in the nature or status of Employee’s
responsibilities, duties, titles or reporting level (unless otherwise agreed to by Employee’s), provided, however, that notwithstanding the foregoing, for purposes of this subsection (iv), a substantial diminution in such nature or status
shall not exist in the event that due to a Change in Control the Employee has authority and responsibility over a division, subsidiary or entity that is substantially similar in size to the division, subsidiary or entity over which the
Employee had authority and responsibility immediately prior to such Change in Control; provided, in each case, that the Employee first provided notice to the Company of the existence of the condition described above within fifteen (15) days
of the initial existence of the condition, upon the notice of which the Company shall have thirty (30) days during which it may remedy the condition, and provided further that the separation of service must occur within fifteen (15) days
following the end of such 30-day cure period.
|
14.3. |
“Change in Control” means and includes each of the following:
(a) A transaction or series of transactions (other than an offering of Common Stock to the general public through a registration statement filed with the Securities and Exchange Commission or a transaction or series of transactions that
meets the requirements of clauses (i) and (ii) of subsection (c) below) whereby any “person” or related “group” of “persons” (as such terms are used in Sections 13(d) and 14(d)(2) of the Exchange Act) (other than the Company, any of its
Subsidiaries, an employee benefit plan maintained by the Company or any of its Subsidiaries or a “person” that, prior to such transaction, directly or indirectly controls, is controlled by, or is under common control with, the Company)
directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of securities of the Company possessing more than 50% of the total combined voting power of the Company’s securities outstanding
immediately after such acquisition; or (b) During any period of twenty-four consecutive months, individuals who, at the beginning of such period, constitute the Board together with any new Director(s) (other than a Director designated by a
person who shall have entered into an agreement with the Company to effect a transaction described in subsections (a) or (c)) whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at
least two-thirds of the Directors then still in office who either were Directors at the beginning of the twenty-four month period or whose election or nomination for election was previously so approved, cease for any reason to constitute a
majority thereof; or (c) The consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more intermediaries) of (x) a merger, consolidation, reorganization, or business combination
or (y) a sale or other disposition of all or substantially all of the Company’s assets in any single transaction or series of related transactions or (z) the acquisition of assets or stock of another entity, in each case other than a
transaction: (i) which results in the Company’s voting securities outstanding immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the Company or the
person that, as a result of the transaction, controls, directly or indirectly, the Company or owns, directly or indirectly, all or substantially all of the Company’s assets or otherwise succeeds to the business of the Company (the Company
or such person, the “Successor Entity”)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and (ii) after which no person or
group beneficially owns voting securities representing 50% or more of the combined voting power of the Successor Entity; provided, however, that no person or group shall be treated for purposes of this clause (ii) as beneficially owning 50%
or more of the combined voting power of the Successor Entity solely as a result of the voting power held in the Company prior to the consummation of the transaction. Notwithstanding the foregoing, if a Change in Control constitutes a
payment event with respect to any Award (or portion of any Award) that provides for the deferral of compensation that is subject to Section 409A, to the extent required to avoid the imposition of additional taxes under Section 409A, the
transaction or event described in subsection (a), (b) or (c) with respect to such Award (or portion thereof) shall only constitute a Change in Control for purposes of the payment timing of such Award if such transaction also constitutes a
“change in control event,” as defined in Treasury Regulation Section 1.409A- 3(i)(5). The Administrator shall have full and final authority, which shall be exercised in its discretion, to determine conclusively whether a Change in Control
has occurred pursuant to the above definition, the date of the occurrence of such Change in Control and any incidental matters relating thereto; provided that any exercise of authority in conjunction with a determination of whether a Change
in Control is a “change in control event” as defined in Treasury Regulation Section 1.409A-3(i)(5) shall be consistent with such regulation.
|
By:
|
||
Name:
|
John Doherty
|
|
Date:
|
January 15, 2024
|
|
SSN:
|
###-##-####
|
|
Address:
|
12485 World Cup Lane
|
|
Wellington, FL 33414
|
1. |
Bonus (MBO)
|
1.1. |
Commencing 2024 (inclusive), the Employee’s total attainable annual Bonus (namely, the 100% MBO On-Target Bonus) shall be in an amount equal to the annual Base Salary
(i.e., $470,000).
|
1.2. |
The Employee’s entitlement to an annual Bonus for the calendar year of 2024 shall be determined, for such year only, on the basis of the Employee’s and the Company’s
attainment of certain goals and objectives defined by the Company, which are set forth in the Employee’s annual bonus plan according to Company’s 2024 Executive Compensation Plan as shall be approved by the Company’s Compensation Committee
of the Company , a summary of which is enclosed as Exhibit A.1.(a) hereof (the “2024 Executive Compensation Plan”), as follows:
|
1.2.1. |
The potential maximum annual Bonus with respect to 100% attainment, satisfaction and performance against the 2024 Executive Compensation Plan’s targets and thresholds
(namely, Individual Objectives and Company Financial Goals KPIs and OKRs) as elaborated or shall be elaborated in the 2024 Executive Compensation Plan, shall equal the gross amount of USD 470,000 (herein, the “Base OTB”).
|
1.2.2. |
The potential maximum annual Additional Stretch Bonus for overachievement against such goals (>100%), may equal up to the gross amount of USD 176,250.
|
1.3. |
Notwithstanding anything to the contrary in the Employment Agreement or any other agreements, arrangements, undertakings, obligations, representations, warranties
and/or understandings, either oral, in writing or otherwise, relating to the Employee’s employment and/or grant of services and/or any other engagement, entered into or to be entered into between the Parties, the monetary value of the Base
OTB to which the Employee shall be entitled under the 2024 Executive Compensation Plan up to 100% attainment, shall be granted in the form of the number of Restricted Stock Units (as defined in the Kaltura, Inc. 2021 Incentive Award Plan;
the “Equity Incentive Plan”) having a Fair Market Value (as defined in the Equity Incentive Plan) as shall be determined by the
Compensation Committee of the Board of Directors Company (“Compensation Committee”), to be settled in shares in accordance with the
calculation and vesting terms set forth in the 2024 Executive Compensation Plan (the “MBO RSUs”), while any excess entitlement earned by
the Employee for MBO overachievement up to the maximum Annual Additional Stretch Bonus (i.e., >100% attainment of the applicable goals under the 2024 Executive Compensation Plan) will be paid in cash in accordance with the entitlement
and payment terms set forth under the 2024 Executive Compensation Plan.
|
1.4. |
Except as set forth in Sections 1.2 and 1.3 above with respect to the 2024 annual Bonus, the Employee’s entitlement to annual Bonus and Additional Stretch Bonus shall
be determined, for each subsequent calendar year, on the basis of the attainment of certain financial and operational metrics set by Kaltura, Inc.’s Board of Directors or Compensation Committee and shall be payable in cash.
|
1.5. |
All Bonus payments, if any, shall be subject to all mandatory withholdings and deductions, and shall be deemed to be quoted in gross figures. In addition, all Bonus
payments in currencies other than US Dollar (for 2024, the Additional Stretch Bonus payment) will be adjusted in accordance with the specific payment currency and US Dollar exchange rate that shall prevail as of the payment calculation date
in accordance with the Company’s policies and procedures.
|
2. |
2024 MBO RSUs Terms of Grant
|
2.1. |
Grant Date: effective as of the effective date of the Compensation
Committee’s approval of the 2024 Executive Compensation Plan (expected to occur in February 2024).
|
2.2. |
Vesting: Up to the maximum number of the MBO RSUs that were granted to the
Employee will be eligible to vest in accordance with the satisfaction and performance against the 2024 Executive Compensation Plan’s targets and thresholds (namely, 25% based on Individual Objectives and 75% based on the Company Financial
Goals KPIs and OKRs set forth in Annex A,1(a) (with 100% achievement of such Company Financial Goals upon attainment of the Company’s formal plan and budget for 2024), upon and subject to the eligibility of the Employee to the cash payment
of the Annual Bonus but for the conversion thereof to MBO RSUs which shall be determined following the approval of the final audited results for FY-24 (expected no later than March 15, 2025), subject, however, to the continued employment of the Employee through December 31, 2024.
|
2.3. |
Contingencies: the MBO RSUs award shall be made pursuant to the Equity
Incentive Plan, the 2024 Executive Compensation Plan and the appropriate award agreement to be executed by the Employee and countersigned by Kaltura, Inc., and to the execution and delivery of all required agreements and instruments
pursuant to the Equity Incentive Plan and Kaltura, Inc.’s policies.
|
2.4. |
Double trigger (Corporate Transactions; Change of Control): the MBO RSUs
shall be subject to the “double trigger” mechanism as set forth in the Equity Incentive Plan (Sections 8.2, 8.3 and 11.6 thereof).
|
3. |
Initial LTI Benefit
|
3.1. |
Subject to the approval of the Compensation Committee of the Board of Directors of Kaltura, Inc., the Company anticipates granting the Employee the number of
additional Restricted Stock Units having a Fair Market Value as shall be determined by the Compensation Committee, equal to $2,060,000 (two million sixty thousand US Dollars), as shall be stipulated in the 2024 Executive Compensation Plan
(herein, “LTI RSUs”).
|
3.2. |
The LTI RSUs will be governed by the terms and conditions of the Company’s Equity Incentive Plan, the respective provisions of the 2024 Executive Compensation Plan
and applicable award agreements.
|
3.2.1. |
Grant Date: within 5 working days from the Effective Date.
|
3.2.2. |
Vesting: Three-year vesting period from the Effective Date, with a one-year
cliff and then quarterly vesting thereafter, subject to the Employee’s continued employment through each applicable vesting date.
|
3.2.3. |
Double trigger (Corporate Transactions; Change of Control): the LTI RSUs
shall be subject to the “double trigger” mechanism as set forth in the Equity Incentive Plan (Sections 8.2, 8.3 and 11.6 thereof).
|
3.3. |
Contingencies: the LTI RSUs award shall be made pursuant to the Equity
Incentive Plan, the 2024 Executive Compensation Plan and the appropriate award agreement to be executed by the Employee and countersigned by Kaltura, Inc., and to the execution and delivery of all required agreements and instruments
pursuant to the Equity Incentive Plan and Kaltura, Inc.’s policies.
|
4. |
Any annual bonus will be paid no later than March 15th of the immediately following calendar year. Except as provided in Section 13 (Severance Pay) of the
Offer Letter with respect to the pro-rated annual bonus payable in connection with certain termination of employment, you must remain actively and continuously employed commencing on the Effective Date, and not in a notice period, through
the bonus payment date to be eligible to receive an annual bonus payment for a particular calendar year.
|
1. |
MBO Bonus Plan Parameters
|
1.1. |
Individual Objectives: 25% based on Annual OKRs
|
1.2. |
Company Financial Goals: 75% based on the Company’s 2024 year-end financial results vs. 2024 budget allocated as shall be set forth in the Plan, which allocation may
include components such as Company Subscription Revenue, Company Total Revenue, Net New ARR Addition, Company Adjusted EBITDA, and the like.
|
1.3. |
Overachievement may entitle up to 137.5% of MBO stretch amount, while the excess layer above the 100% MBO attainment, if and as shall be achieved, will be paid in
cash.
|
1.4. |
Equity Awards: Constitutes of two types of grants: MBO RSUs and 2024 LTI
RSUs, as further detailed below.
|
1.5. |
Bonus: The potential annual variable cash bonus (namely, the On-Target
Bonus; “OTB”) up to 100% MBO attainment, if and as shall be achieved, will be converted into and paid by virtue of the grant of MBO RSUs
as further detailed below and in the Plan. Any excess OTB portion above the 100% attainment (namely, the over-attainment/stretch amount), will be paid in cash, if and to the extent applicable.
|
2. |
MBO RSUs
|
2.1. |
Reflects Cash Bonus Conversion to MBO RSUs as aforesaid.
|
2.2. |
Subject to the following principal terms:
|
2.2.1. |
Grant Date: within 5 working days from the Effective Date.
|
2.2.2. |
Vesting: in one tranche upon and subject to entitlement to 2024 annual MBO
cash Bonus but for the conversion to MBO RSUs, subject to continued employment on December 31st, 2024.
|
2.2.3. |
Number of RSUs: The number of MBO RSUs will be based on OTB (On-Target
Bonus) MBO entitlement of up to 100% attainment, if and as shall be achieved (pro-rata).
|
2.2.4. |
Cliff (Threshold): If either of the Total Revenue or Adjusted EBITDA KPIs
(or other KPIs as shall be determine by the Compensation Committee) is missed (i.e., attainment of 50% or under), then no Bonus will be paid or MBO RSUs awarded, regardless the attainment levels of all other KPIs.
|
2.2.5. |
Acceleration: Double Trigger acceleration in accordance with the Company’s
2021 Incentive Award Plan and/or applicable award agreements thereunder.
|
3. |
2024 LTI RSUs
|
3.1. |
Individual award as detailed in the Plan and the grant documents.
|
3.2. |
Subject to the following principal terms:
|
3.2.1. |
Grant Date: within 5 working days from the Effective Date.
|
3.2.2. |
Vesting: Three-year vesting period from the Effective Date, with a one-year
cliff and then quarterly vesting thereafter, subject to the Employee’s continued employment through each applicable vesting date.
|
3.2.3. |
Acceleration: Double Trigger acceleration in accordance with the Company’s
2021 Incentive Award Plan and/or applicable award agreements thereunder.
|
1. |
You will be eligible for a variable annual variable MBO cash bonus of up to 100% of your Base Salary each calendar year (less applicable taxes) commencing January 1st,
2025, based on Kaltura’s achievement of company-level financial performance goals, and your OKR performance as per company OKR Measurement plan.
|
2. |
The variable annual variable MBO cash bonus mechanism may include acceleration in the case of overachievement, paid in cash, and cliff in the case of threshold
non-achievement, were there shall be no Bonus entitlement.
|
3. |
Any annual bonus with respect to a particular calendar year will be paid no later than March 15th of the immediately following calendar year. Subject to
Section 13 (Severance Pay) of the offer Letter with respect to the first 12 month of employment, for any partial subsequent calendar year, you will be eligible for a pro-rated annual bonus based on the number of days you are employed by
Kaltura during the applicable calendar year. Notwithstanding the foregoing, you must remain actively and continuously employed, and not on a notice period, through the bonus payment date to be eligible to receive an annual bonus payment for
a particular calendar year.
|
1. |
I represent and warrant that my employment with the Company does not conflict with, violate or breach any of the terms, conditions and provisions of any agreement,
contract, license or other commitment to which I am a party or by which I am bound, including any obligation to or agreement with any previous or current employer or third party.
|
2. |
I further represent and warrant that (i) I have obtained any and all consents, permits and approvals required in connection with my employment with the Company from
any person and entity; (ii) no legal impediment exists with respect to my employment with the Company; and (iii) the services and work performed by me for or on behalf of the Company will not infringe upon any copyright, patent, trademark,
trade secret or other proprietary right of any third party, including, without limitation, any current or former employer.
|
3. |
I further represent and warrant that my employment by Company does not violate or breach any obligations towards any of my former employers and I agree to indemnify
and hold the Company harmless with respect to any third-party claim brought against the Company related to such prior employment, and I explicitly release Company from any liability with respect to claims that might be brought against me or
the Company in that respect, whether by contract, or any other legal theory.
|
4. |
I undertake to promptly inform the Company if any of the above representations and warranties changes and/or if any consent required has expired or is otherwise not
in effect.
|
5. |
I will disclose the existence of my employment with the Company to any previous or current employer or third party if required to do so under applicable law or
contract.
|
6. |
I hereby authorize the Company to use, reuse, and to grant others the right to use and reuse my name, photograph, likeness (including caricature), voice, and
biographical information, and any reproduction or simulation thereof, in any media now known or hereafter developed (including but not limited to film, video, and digital or other electronic media), both during and after my employment, for
whatever purposes the Company deems necessary.
|
By:
|
||
Name:
|
John Doherty
|
|
Title:
|
CFO
|
|
Date:
|
January 15, 2024
|
1. |
Confidential Information
|
1.1. |
Confidentiality. Except as herein provided, Employee agrees that during and after termination of his or her employment with the Company, he or she (i) shall keep Confidential Information (as defined below) confidential and
shall not directly or indirectly, use, divulge, publish or otherwise disclose or allow to be disclosed any aspect of Confidential Information without the Company’s prior written consent; (ii) shall refrain from any action or conduct which
might reasonably or foreseeably be expected to compromise the confidentiality or proprietary nature of the Confidential Information; and (iii) shall follow recommendations made by the Board of Directors, officers or supervisors of the
Company from time to time regarding Confidential Information. “Confidential Information” includes but is not limited to Inventions (as
defined in section 2(b)), trade secrets, confidential information, knowledge or data of the Company, or any of its clients, customers, consultants, shareholders, licensees, licensors, vendors or affiliates, that Employee may produce, obtain
or otherwise acquire or have access to during the course of his or her employment by the Company (whether before or after the date of this Agreement), including but not limited to: business plans, records, and affairs; customer files and
lists; special customer matters; sales practices; methods and techniques; merchandising concepts, strategies and plans; sources of supply and vendors; special business relationships with vendors, agents, and brokers; promotional materials
and information; financial matters; mergers; acquisitions; equipment, technologies and processes; selective personnel matters; inventions; developments; product specifications; procedures; pricing information; intellectual property;
know-how; technical data; software programs; algorithms; operations and production costs; processes; designs; formulas; ideas; plans; devices; materials; and other similar matters which are confidential. All Confidential Information and all
tangible materials containing Confidential Information are and shall remain the sole property of the Company.
|
1.2. |
Limitation. Employee shall have no obligation under this Agreement to
maintain in confidence any information that (i) is in the public domain at the time of disclosure, (ii) though originally Confidential Information, subsequently enters the public domain other than by breach of Employee’s obligations
hereunder or by breach of another person’s or entity’s confidentiality obligation, or (iii) is in Employee’s possession or known to Employee prior to employment with the Company after being provided to the Employee by a third party not
obligated to any confidentiality obligations vis-à-vis the Company or from the Company under no confidentiality or limitation. Nothing in this agreement prevents Employee from discussing or disclosing information about unlawful acts in the
workplace, such as harassment or discrimination or any other conduct that Employee has reason to believe is unlawful.
|
1.3. |
Former Employer Information. Employee agrees that he or she has not and
will not, during the term of his or her employment, (i) improperly use or disclose any proprietary information or trade secrets of any former employer or other person or entity with which Employee has an agreement or duty to keep in
confidence information acquired by Employee, if any, or (ii) bring onto the premises of the Company any document or confidential or proprietary information belonging to such employer, person or entity unless consented to in writing by such
employer, person or entity. Employee will defend and indemnify the Company and hold it harmless from and against all claims, liabilities, damages and expenses, including reasonable attorneys’ fees and costs of suit, arising out of or in
connection with any violation of the foregoing.
|
1.4. |
Third Party Information. Employee recognizes that the Company may have
received, and in the future may receive, confidential or proprietary information from third parties that is subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain limited
purposes. Employee agrees that he or she owes the Company and such third parties, during Employee’s employment by the Company and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence and
not to disclose it to any person or firm and to use it in a manner consistent with, and for the limited purposes permitted by, the Company’s agreement with such third party.
|
1.5. |
Conflicting Activities. While employed by the Company, Employee will not
work as an employee or consultant of any other organization or engage in any other activities which conflict, directly or indirectly, with Employee’s obligations to the Company without the express prior written approval of the Company.
|
1.6. |
Defend Trade Secrets Act Notice of Immunity Rights. Employee acknowledges
that the Company has provided the following notice of immunity rights in compliance with the requirements of the Defend Trade Secrets Act: (i) Employee shall not be held criminally or civilly liable under any Federal or State trade secret
law for the disclosure of Confidential Information that is made in confidence to a Federal, State, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, (ii)
Employee shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of Confidential Information that is made in a complaint or other document filed in a lawsuit or other proceeding, if such
filing is made under seal and (iii) if Employee files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Employee may disclose the Confidential Information to Employee’s attorney and use the Confidential
Information in the court proceeding, if Employee files any document containing the Confidential Information under seal, and does not disclose the Confidential Information, except pursuant to court order.
|
2. |
Inventions
|
2.1. |
Inventions Retained and Licensed. Employee represents that there are no
Prior Inventions (as defined below). Employee hereby acknowledges that, if in the course of his or her service for Company, Employee incorporates into a Company product, process or machine a Prior Invention owned by Employee or in which he
or she has an interest, the Company is hereby granted and shall have a fully paid, nonexclusive, royalty-free, irrevocable, perpetual, worldwide, transferable and sublicensable right and license to make, have made, modify, create derivative
works, reproduce, use, offer to sell, sell, sublicense and otherwise distribute such Prior Invention (as may be improved or enhanced by or for the Company) and in the event of copyrightable materials, copy, distribute, publicly perform,
publicly display, make derivative works thereof, and sublicense such copyrightable materials, as part of or in connection with such product, process or machine.
|
2.2. |
Assignment of Inventions. Except as provided in Section 2(e) hereof,
Employee hereby assigns and transfers to the Company, to the fullest extent under applicable law, his or her entire right, title and interest in and to all inventions, ideas, improvements, designs, developments, works, Company-specific
know-how, original works of authorship, formulae, ideas, concepts, techniques, methods, systems, processes, compositions of matter, algorithms, computer software programs (including, but not limited to, any code, modules, tools, and
libraries), databases, trade secrets and discoveries and any other intellectual creations of any nature whatsoever (the “Inventions”),
whether or not patentable and whether or not reduced to practice, made or conceived by Employee, whether solely by Employee or jointly with others, during the period and within the scope of or in connection with his or her employment with
Company that (i) relate in any manner to the actual or demonstrably anticipated business, work, or research and development of the Company, its affiliates or subsidiaries, (ii) are developed in whole or in part on the Company’s time or
using the Company’s equipment, supplies, facilities or Confidential Information, or (iii) result from or are suggested by any task assigned to Employee or any work performed by Employee for or on behalf of the Company, its affiliates or
subsidiaries, or by the scope of Employee’s duties and responsibilities with the Company, its affiliates or subsidiaries. In the event that Employee believes that he or she is entitled to ownership, either in whole or in part, of an
Invention pursuant to Section 2(e) hereof, he or she shall notify the Company of such in writing. Except in such cases as the Board of Directors of Company confirms in writing that Employee is entitled to ownership, Employee agrees that all
Inventions are the sole property of the Company. Employee further acknowledges that all original works of authorship that are made by Employee, solely or jointly with others, within the scope of and during the period of Employee’s
employment by the Company and that are protectable by copyright are “works made for hire,” as defined in the U.S. Copyright Act and shall be owned solely by the Company. Without derogating from the aforementioned, the Employee hereby
explicitly waives any interest, claim or demand that the Employee may have for, or may be entitled to, with respect to any consideration, compensation or royalty in connection with the Inventions. The Employee hereby acknowledges and
declares that the monthly salary and any other benefits provided under the offer letter to which this Exhibit is attached, constitutes the entire compensation to which he/she is entitled to and includes any and all consideration with
respect to the Inventions developed by him/her. The Employee further waives the right to bring any claims, demands or allegations to receive compensation, consideration or royalty with respect to the Moral Rights (as defined below).
|
2.3. |
Disclosure of Inventions. Employee agrees that in connection with any
Invention: (i) Employee shall promptly disclose such Invention in writing to his or her immediate supervisor at the Company (which shall be received in confidence by the Company), with a copy to the Company, regardless of whether Employee
believes the Invention is covered by Section 2(e), in order to permit Company to claim rights to which it may be entitled under this Agreement; and (ii) Employee shall, at the Company’s request, promptly execute a written assignment of
title to the Company for any Invention required to be assigned by Section 2(b) (an “Assignable Invention”), and Employee will preserve
any such Assignable Invention as Confidential Information of the Company.
|
2.4. |
Patent and Copyright Registrations. Employee agrees to assist the Company,
or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Assignable Inventions and any copyrights, patents, mask work rights or other intellectual property rights relating thereto in any and all
countries, including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and other instruments that the Company may deem necessary
in order to apply for and obtain such rights and in order to assign and convey to Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Assignable Inventions, and any copyrights,
patents, or other intellectual property rights relating thereto. Employee further agrees that his or her obligation to execute or cause to be executed, when it is in his or her power to do so, any such instrument or papers shall continue
after the termination of Employee’s employment by the Company. If the Company is unable because of Employee’s mental or physical incapacity or for any other reason to secure Employee’s signature to apply for or to pursue any application for
any U.S. or other patents or copyright registrations covering Assignable Inventions or original works of authorship assigned to the Company as above, then Employee hereby irrevocably designates and appoints the Company and its duly
authorized officers and agents as Employee’s agent and attorney-in-fact, to act for and in Employee’s behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and
issuance of letters patent or copyright registrations thereon with the same legal force and effect as if executed by Employee.
|
2.5. |
Exception to Assignments. Assignable Inventions shall not include any
Invention (i) that Employee develops entirely on Employee’s own time, (ii) without use of any Company assets and (iii) which is not useful with and does not relate to the Company’s actual or proposed business, products or research and
development.
|
2.6. |
Other Obligations. Employee acknowledges that Company from time to time may
have agreements with other persons or with the U.S. or other governments, or agencies thereof, that impose obligations or restrictions on the Company regarding Inventions made during the course of work thereunder or regarding the
confidential nature of such work. Employee agrees to be bound by all such obligations and restrictions and to take all action necessary to discharge the obligations of the Company thereunder.
|
3. |
Return of Confidential Material
|
4. |
Notification of New Employer
|
5. |
Non-Solicitation and Non-Competition
|
5.1. |
Restrictions. Employee agrees that during the period of his or her
employment with the Company and for six (6) months after the date of termination of his or her employment with the Company (for any reason or no reason, whether voluntary or involuntary), he or she will not (i) induce, solicit, recruit or
encourage (or endeavor to induce, solicit, recruit or encourage) any employee or consultant of the Company to leave the employ of the Company, (ii) solicit the business of any client or customer of the Company (other than on behalf of the
Company), (iii) engage in any activity that is directly competitive with the business or demonstrably anticipated business of the Company (iv) carry on or hold an interest in any corporation, venture, entity or other business (other than a
minority interest in a publicly traded company) which competes with the products or services of the Company, or (v) assist any other person or organization in competing or in preparing to compete with any business or demonstrably
anticipated business of the Company or act as an employee, officer consultant or in any managerial capacity in a business in competition with the Company.
|
5.2. |
Enforcement. If at any time any of the provisions of Section 5(a) are
deemed invalid or unenforceable or are prohibited by the laws of the state or place where they are to be performed or enforced, by reason of being vague or unreasonable as to duration or geographic scope or scope of activities restricted,
or for any other reason, such provisions shall be considered divisible and shall become and be immediately amended to include only such restrictions and to such extent as shall be deemed to be reasonable and enforceable by the court or
other body having jurisdiction over this Agreement. The provisions of Section 5(a), as so amended, shall be valid and binding as though any invalid or unenforceable provision had not been included.
|
6. |
Representations
|
7. |
Equitable Relief
|
8. |
Governing Law; Consent to Personal Jurisdiction
|
9. |
Entire Agreement
|
10. |
Severability
|
11. |
Successors and Assigns
|
12. |
Counterparts
|
13. |
No Employment Contract
|
Kaltura, Inc.
|
Employee
|
||||
By:
|
By:
|
||||
Name:
|
Sigal Srur
|
Name:
|
John Doherty
|
||
Title:
|
Chief HR Officer
|
Date:
|
January 15, 2024
|
||
Date:
|
January 15, 2024
|
1. |
Further to your Resignation Notice and to the discussions held between you and the Company, this letter of agreement (“Letter of Agreement” or “LOA”) records and sets forth the terms agreed
between you and the Company relating to the separation and termination of employment between you and the Company (each a “Party” and
collectively the “Parties”):
|
1.1. |
Except as explicitly specified herein, (i) the Employment Agreement, and (ii) all any other agreements, arrangements, undertakings, obligations, representations,
warranties, drafts and/or understandings, either oral, in writing or otherwise, relating to your employment and/or grant of services and/or any other engagement, entered into between you and the Company, shall terminate and your employment
with the Company shall end on July 10, 2024 (the “Effective Date of Termination”), save for such terms that survive termination in
accordance with the provisions thereof. Notwithstanding anything to the contrary in the Employment Agreement, the period from July 1, 2024 until the Effective Date of Termination, shall be paid time off (e.g., vacation time).
|
1.2. |
Until February 29, 2024 (inclusive), you will continue serving the Company at your current position as the Company’s Chief Financial Officer and Principal Accounting
Officer. In that capacity, you shall be in charge of the Company’s 2023 financial statements for the period ending December 31, 2023, the filing thereof on Form 10-K with the U.S. Securities and Exchange Commission (“SEC”) and related activities (such as, but not limited to, 2023 YE earning call, investors’ calls etc.). Notwithstanding anything to the contrary in the
Employment Agreement, from March 1st, 2024 until the Effective Date of Termination, you shall serve as a special assistant to the CEO and your successor CFO, and in addition, shall assure a smooth, orderly, handover and
transition of the management of the finance department’s activities to the new CFO, as shall be requested (the period commencing the date hereof and ending at the Effective Date of Termination, shall be referred to herein as the “Transition Period”).
|
1.3. |
The Company hereby agrees that the arrangement set forth in this Letter of Agreement, shall be in lieu of the 60-days prior notice you were obligated to provide under
Clause 5.2, Exhibit A, of the Employment Agreement, and that the last 60-days of your employment term under Section 1.2 above, shall be deemed for all purposes as the notice period.
|
Kaltura, Inc. • 860 Broadway, 3rd Floor New York, NY 10003 • Tel: 646-290-5445
Kaltura (Europe) Ltd. • 4th Floor, LABs House, 16-19 Bloomsbury, London, WC1A 2BA, UK
Kaltura Ltd. • Allied Tower, 9 Ben-Gurion Road, Bnei-Brak, Israel 5126014
www.kaltura.com
|
1.4. |
Except as explicitly specified herein, during the Transition Period your rights and obligations under the Employment Agreement and any applicable law (including,
without limitation, your duty of care and duty of loyalty as a Company executive) shall remain unchanged. Thereafter, you shall be entitled to certain rights and privileges specifically set forth hereinbelow.
|
2. |
During the Transition Period the following provisions shall apply:
|
2.1. |
You shall continue to act as the Company’s Chief Financial Officer and Principal Accounting Officer, including the performance of any and all tasks and
responsibilities associated therewith, until February 29, 2024.
|
2.2. |
On March 1st, 2024, you shall cease to serve as CFO and Principal Accounting Officer, and shall no longer be designated an “officer” of the Company for the
purposes of Section 16 of the Exchange Act nor designated as an “executive officer” of the Company for purposes of Rule 3b-7 under the Exchange Act.
|
2.3. |
Your signatory rights on behalf of the Company shall lapse and expire on March 1, 2024, unless notified otherwise by the Company.
|
2.4. |
You shall continue to serve as a board member at the Board of Directors of Kaltura Germany GmbH (herein, “Kaltura Germany”), until December 31, 2024. Simultaneously with the signing of this letter you shall sign and execute a resignation letter from Kaltura Germany’s Board of Directors which
shall be surrendered to the Company’s General Counsel and held in trust until such date.
|
2.5. |
You shall continue to receive your base salary, remuneration and benefits in accordance with the Employment Agreement and subject to its terms (collectively, the “Base Salary”), until June 30, 2024, and thereafter you shall be at paid-time-off vacation days until the Effective Date of Termination.
|
2.6. |
The Company shall forfeiture all the Option and Stock Appreciation Right (namely, all the Options and/or RSUs) which have been granted to you under any and all equity
award agreements, including award agreements under the Kaltura, Inc. 2021 Incentive Award Plan and Israeli Sub-Plan or previous plans that are still in effect (collectively, the “Plans”; the “Options and RSUs”), that had NOT vested on or before the Effective Date of
Termination and shall be unexercisable as of such date, and such unvested and unexercisable Options and RSUs shall be cancelled and annulled as of the Effective Date of Termination.
|
2.7. |
You will be eligible to receive performance-based compensation under the Company’s 2024 Executive Compensation Plan for Q1, 2024 only (the “Annual Bonus”) as follows:
|
2.7.1. |
Your total attainable Annual Bonus (namely, the 100% MBO On-Target Bonus) shall be in an amount equal to 85% (eighty five percent) of your OTE Q1 MBO value, namely
NIS 216,686, at the NIS/USD exchange rate as shall be determined by the Compensation Committee at the Grant Date.
|
2.7.2. |
The said amount reflects the mutually agreed estimation of the Company’s Q1, 2024 target results. The said amount is hereby fixed regardless of the actual results de
facto. You shall not be entitled to a stretch bonus for overachievement, even if the actual results shall exceed the Parties’ estimation.
|
2.7.3. |
The monetary value of the Annual Bonus shall be granted in the form of the number of Restricted Stock Units (as defined in the Kaltura, Inc. 2021 Incentive Award
Plan; herein the “RSUs” and the “Plan”,
respectively) having a Fair Market Value (as defined in the Plan) as shall be determined by the Compensation Committee, to be settled in shares as follows:
|
- |
Grant Date: effective as of the effective date of the Compensation Committee’s approval of the 2024 Executive Compensation Plan (expected to occur in February 2024).
|
- |
Vesting: June 30, 2024.
|
- |
Contingencies: the RSUs award shall be made pursuant to the Plan, the applicable terms of the 2024 Executive Compensation Plan and the appropriate award agreement,
and to the execution and delivery of all required agreements and instruments pursuant to the Plan and Company policies.
|
3. |
In addition, during the Transition Period and thereafter, you shall execute and sign, and do all such acts and things as may be reasonably required, necessary, useful
or desirable for the removal and replacement of your nomination with any corporate body or entity at which you are serving or in which you are recorded as serving on behalf of the Company.
|
4. |
Subject to your signature below, and as full and final settlement between you and the Company, in the framework of conducting your final settlement of accounts (to be
conducted on or following the Effective Date of Termination), the Company shall pay you a final aggregate amount which shall be comprised of the following:
|
4.1. |
The aggregate consideration entitled by you for the period ending on the Effective Date of Termination.
|
4.2. |
The Company shall redeem the annual leave (e.g., vacation days/days of paid time off) accrued by you from July 1, 2024 until July 10, 2024 plus any remaining balance
that had not been exercised on or before the Effective Date of Termination, at such date.
|
5. |
Notwithstanding anything to the contrary in your Employment Agreement, you shall not be entitled to annul cash bonus (MBO variable cash compensation plan) for 2024 or
any part thereof except as explicitly set forth in Section 2.7 above.
|
6. |
Any and all payments and expense reimbursement shall be made to you in accordance with the Employment Agreement and the applicable laws. Any and all payments
hereunder shall be subject to any applicable statutory deductions and withholdings. You acknowledge that you shall bear any and all taxes associated with the above payments and/or rights, save where explicitly specified otherwise in
writing. The Company shall be entitled to set-off any amounts due to you hereunder from any amounts whatsoever owed by you (if owed) to it or any of its affiliates.
|
7. |
You hereby certify that you have complied, and agree to comply with, all the terms and conditions of your Employment Agreement with Company relating to secrecy,
non-disclosure, non-compete, ownership of property and rights (including Intellectual Property) undertakings, the terms of which are hereby incorporated by reference.
|
8. |
You further undertake, in accordance with the Employment Agreement, and except as expressly set forth in this Letter of Agreement, to return to the Company, by no
later than the Effective Date of Termination, all equipment and items placed at your disposal by the Company and any of its affiliates, including without limitation any item, document and/or materials in your possession and that belongs to
the Company or otherwise relating to the Company’s business, without retaining any copies thereof.
|
9. |
The Company hereby confirms that (i) the Company’s D&O Insurance Policy covers current and former directors and officers of the Company (as such terms are defined
in the policy) on a “Claims Made Basis”, and accordingly, you shall remain covered under such insurance policy and any extensions thereof, subject to the policy’s thresholds, deductibles, contingencies, terms and conditions; and (ii)
subject to the Company’s corporate approvals, the Company intends to continue renewing the D&O Insurance Policy substantially in the terms prevailing as of the date hereof.
|
10. |
Without derogating from the foregoing, you hereby acknowledge that, subject to the Company’s fulfillment of its undertakings under this Letter of Agreement, you
hereby specifically, unconditionally, irrevocably and perpetually release, waives, and forever discharges the Company and any of its officers, shareholders, directors, employees, affiliates and related companies (jointly and severally, the
“Company Group”), from any and all claims, demands, actions, liabilities and causes of actions, of every kind and character, in law or in
equity, for or by reason of any matter or cause whatsoever, that you may possess against the Company Group, arising from or connected to your employment with the Company, and termination of such employment, if and to the extent applicable.
|
11. |
You hereby agree that the existence of this Letter of Agreement and its content shall be considered “Confidential Information” pursuant to the Employment Agreement
(subject to any disclosure obligations of the Company that may apply), save to any disclosure requirements under law.
|
12. |
This Letter of Agreement shall serve as a certificate for the termination of the employment relationship between you and the Company, which will end on Effective Date
of Termination.
|
13. |
Neither Party shall assign or otherwise transfer any of its rights or obligations under this Letter of Agreement to any third party without the prior written consent
of the other Party and any attempted assignment or transfer without such prior written consent shall be null and void.
|
14. |
In the event that any provision of this Letter of Agreement is declared invalid, illegal or unenforceable, the validity, legality or enforceability of the remaining
provisions shall not in any way be affected nor impaired thereby.
|
15. |
This Letter of Agreement constitutes the entire agreement between you and the Company with respect to the termination of the Employment Agreement, including, without
limitation, the terms to which you are entitled in connection with your resignation and employment termination, and hereby cancels and replaces any previous agreement, arrangement, undertaking, obligation, representation, warranty, draft
and/or understanding, either oral, in writing or otherwise, pertaining to the termination of your employment. In any case of discrepancy, inconsistence or contradiction between this Letter of Agreement and the Employment Agreement, the
provisions of this Letter of Agreement shall prevail. Save as expressly superseded, supplemented and amended by this Letter of Agreement, the Employment Agreement shall remain unaltered and in full force and effect. To dispel doubt, the
terms of the provisions of any equity compensation Plan or award, other than with respect to affixing the Participant’s Termination of Service date as the Effective Date of Termination, are and shall remain unchanged and in full force and
effect in accordance with their terms.
|
16. |
This Letter of Agreement shall be deemed also as an agreement for the benefit of third parties with respect to the Company group members who are not a direct party
thereto.
|
17. |
You confirm that your signature of this Letter of Agreement was done freely and willingly and constitutes full and complete waiver of any claim against the Company
group members, in the past, the present and the future, relating to your employment and/or provision of services and the termination of your employment with and/or provision of services to and/or on behalf of the Company.
|
January 16, 2024
|
|||
Mr. Yaron Garmazi
|
Date
|